Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

antiplatelet

antiplatelet is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 11
News articles 0
Drug details — antiplatelet
Class
—
Route
—
Patents
2
Programs
11
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

antiplatelet is an FDA-listed pharmaceutical active ingredient.

Key facts

INN antiplatelet

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. CAMER5UA Phase 3 · United Therapeutics Europe · Cervical Artery Dissection
  2. Platelet Rich Plasma Phase 3 · Hospital Authority · Severe Oligoasthenoteratozoospermia
  3. Platelet Rich Plasma Injection Phase 3 · United Therapeutics Europe · Osteoarthritis of the Shoulder
  4. Platelet rich plasma Phase 3 · Lxo Ireland Designated · Coxarthrosis
  5. Start antiplatelet monotherapy Phase 3 · Chinese Academy of · Intracerebral Hemorrhage
  6. 22375 Phase 1 · Bayer · Prevention of ischemic stroke in patients after an acute non
  7. Combination of antiplatelet drugs and anticoagulants for at least one month Approved · First People's Hospital · Acute Myocardial Infarction
  8. De-escalated Dual Antiplatelet Therapy Approved · Chinese Academy of · Coronary Artery Disease

Related patents

Browse patents

  1. US 12410132

    Antiplatelet drugs and uses thereof

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11834413

    Antiplatelet drugs and uses thereof

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is antiplatelet?

antiplatelet is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.